(1 - 10 von 14
)
Allergan and Gedeon Richter Receive U.S. FDA Approval For ...news.abbvie.com › news › allergan-press-releases
news.abbvie.com
· Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression.
Allergan, Gedeon Richter plan depression submission | BioPharma ...www.biopharmadive.com › news › allergan-gedeon...
www.biopharmadive.com
· Allergan plc and Gedeon Richter Plc.'s drug Vraylar (cariprazine) has scored a second success in pivotal studies in acute bipolar I depression.
Gedeon Richter, Forest Drug Cariprazine Succeeds in Third Phase ...www.genengnews.com › ... › Mental Health Disorders
www.genengnews.com
· Gedeon Richter and partner Forest Laboratories reported postive data from a Phase III study investigating the antipsychotic drug cariprazine ...
Gedeon Richter, Actavis report positive top line results from...
www.news-medical.net
Gedeon Richter Plc. and Actavis plc today announced positive results from a Phase III trial evaluating the efficacy and safety of cariprazine in the prevention...
sortiert nach Relevanz / Datum